Comparative Study of Subcutaneous Versus Intravenous IgG Replacement Therapy in Pediatric Patients with Primary Immunodeficiency Diseases: A Multicenter Study in Argentina

被引:0
作者
Liliana Bezrodnik
Andrea Gómez Raccio
Gabriela Belardinelli
Lorena Regairaz
Damacia Díaz Ballve
Gisela Seminario
Ileana Moreira
Carlos Riganti
Claudio Cantisano
Héctor Díaz
Daniela Di Giovanni
机构
[1] Inmunología,
[2] Hospital de Niños “Dr. Ricardo Gutiérrez”,undefined
[3] Inmunología,undefined
[4] Hospital de Niños “Sor María Ludovica”,undefined
[5] Inmunología,undefined
[6] Hospital de Niños Pedro Elizalde,undefined
[7] Inmunología,undefined
[8] Hospital de Niños “Dr. Ricardo Gutiérrez”,undefined
来源
Journal of Clinical Immunology | 2013年 / 33卷
关键词
Argentina; children; immunoglobulin therapy; intravenous; primary immunodeficiency; subcutaneous; Beriglobina P;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1216 / 1222
页数:6
相关论文
共 50 条
  • [21] Comparative study of intravenous high-dose dexamethasone versus intravenous methylprednisolone as an emergent therapy in severe primary immune thrombocytopenia
    Khedr, Hager M.
    Abuelrus, Hanan M.
    Mekawy, Adel H.
    Saleh, Mostafa F. Mohammed
    EGYPTIAN JOURNAL OF HAEMATOLOGY, 2021, 46 (01) : 58 - 63
  • [22] Ethanol lock therapy in pediatric patients: A multicenter prospective study
    Chiba, Masahiro
    Yonekura, Takeo
    Kaji, Tatsuru
    Amae, Shintaro
    Tazuke, Yuko
    Oowari, Mitsugu
    Obana, Kazuko
    Nakano, Miwako
    Kuroda, Tasuo
    Fukumoto, Kouzi
    Yamane, Yusuke
    Yoshino, Hiroaki
    Hebiguchi, Tatsuzo
    Toki, Akira
    PEDIATRICS INTERNATIONAL, 2020, 62 (03) : 379 - 385
  • [23] Immunoglobulin Initiation Among Patients with Primary Immunodeficiency Diseases (PIDD): A Retrospective Claims-based US Cohort Study
    Anderson-Smits, Colin
    Orange, Jordan
    Park, Michelle
    Huang, Zhongwen
    Layton, J. Bradley
    Ritchey, Mary E.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2021, 41 (SUPPL 1) : S96 - S96
  • [24] Impact of Site of Care on Infection Rates Among Patients with Primary Immunodeficiency Diseases Receiving Intravenous Immunoglobulin Therapy
    Wasserman, Richard L.
    Ito, Diane
    Xiong, Yan
    Ye, Xiaolan
    Bonnet, Patrick
    Li-McLeod, Josephine
    JOURNAL OF CLINICAL IMMUNOLOGY, 2017, 37 (02) : 180 - 186
  • [25] Impact of Site of Care on Infection Rates Among Patients with Primary Immunodeficiency Diseases Receiving Intravenous Immunoglobulin Therapy
    Richard L. Wasserman
    Diane Ito
    Yan Xiong
    Xiaolan Ye
    Patrick Bonnet
    Josephine Li-McLeod
    Journal of Clinical Immunology, 2017, 37 : 180 - 186
  • [26] Effectiveness, Safety, and Treatment Satisfaction of 20% Subcutaneous Immunoglobulin Replacement Therapy in Pediatric Patients with Primary and Secondary Immunodeficiencies
    Yildiz, Ceren Ayca
    Gokdemir, Yasemin
    Eralp, Ela Erdem
    Ergenekon, Pinar
    Karakoc, Fazilet
    Karadag, Bulent
    TURKISH ARCHIVES OF PEDIATRICS, 2025, 60 (02):
  • [27] Antibody levels to tetanus, diphtheria, measles and varicella in patients with primary immunodeficiency undergoing intravenous immunoglobulin therapy: a prospective study
    Nobre, Fernanda Aimee
    da Silva Gonzalez, Isabela Garrido
    Simao, Raquel Maria
    de Moraes Pinto, Maria Isabel
    Costa-Carvalho, Beatriz Tavares
    BMC IMMUNOLOGY, 2014, 15
  • [28] A Systematic Review and Meta-regression Analysis on the Impact of Increasing IgG Trough Level on Infection Rates in Primary Immunodeficiency Patients on Intravenous IgG Therapy
    Lee, Jian Lynn
    Shah, Noraida Mohamed
    Makmor-Bakry, Mohd
    Islahudin, Farida Hanim
    Alias, Hamidah
    Noh, Lokman Mohd
    Saffian, Shamin Mohd
    JOURNAL OF CLINICAL IMMUNOLOGY, 2020, 40 (05) : 682 - 698
  • [29] A Systematic Review and Meta-regression Analysis on the Impact of Increasing IgG Trough Level on Infection Rates in Primary Immunodeficiency Patients on Intravenous IgG Therapy
    Jian Lynn Lee
    Noraida Mohamed Shah
    Mohd Makmor-Bakry
    Farida Hanim Islahudin
    Hamidah Alias
    Lokman Mohd Noh
    Shamin Mohd Saffian
    Journal of Clinical Immunology, 2020, 40 : 682 - 698
  • [30] fSCIG 10% in pediatric primary immunodeficiency diseases: a European post-authorization safety study
    Ciznar, Peter
    Roderick, Marion
    Schneiderova, Helen
    Jesenak, Milos
    Krivan, Gergely
    Brodszki, Nicholas
    Jolles, Stephen
    Atisso, Charles
    Fielhauer, Katharina
    Saeed-Khawaja, Shumyla
    McCoy, Barbara
    Yel, Leman
    ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2024, 20 (01):